Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming - Institut Pasteur
Article Dans Une Revue Cell Reports Année : 2022

Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming

Résumé

Cellular senescence is an irreversible growth arrest with a dynamic secretome, termed the senescence-associated secretory phenotype (SASP). Senescence is a cell-intrinsic barrier for reprogramming, whereas the SASP facilitates cell fate conversion in non-senescent cells. However, the mechanisms by which reprogramming- induced senescence regulates cell plasticity are not well understood. Here, we investigate how the heterogeneity of paracrine senescence impacts reprogramming. We show that senescence promotes in vitro reprogramming in a stress-dependent manner. Unbiased proteomics identifies a catalog of SASP factors involved in the cell fate conversion. Amphiregulin (AREG), frequently secreted by senescent cells, promotes in vitro reprogramming by accelerating proliferation and the mesenchymal-epithelial transition via EGFR signaling. AREG treatment diminishes the negative effect of donor age on reprogramming. Finally, AREG enhances in vivo reprogramming in skeletal muscle. Hence, various SASP factors can facilitate cellular plasticity to promote reprogramming and tissue repair.
Fichier principal
Vignette du fichier
1-s2.0-S2211124722008725-main.pdf (4.09 Mo) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

pasteur-04093575 , version 1 (10-05-2023)

Licence

Identifiants

Citer

Mathieu von Joest, Cheng Chen, Thibaut Douché, Jeremy Chantrel, Aurélie Chiche, et al.. Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming. Cell Reports, 2022, 40 (2), pp.111074. ⟨10.1016/j.celrep.2022.111074⟩. ⟨pasteur-04093575⟩
43 Consultations
84 Téléchargements

Altmetric

Partager

More